Year To Quarter End Consolidated Statement Of Comprehensive Income

HISAMITSU PHARMACEUTICAL CO.,INC. - Filing #7335898

Concept 2023-03-01 to
2024-02-29
2023-03-01 to
2024-02-29
2023-03-01 to
2024-02-29
2023-03-01 to
2024-02-29
2023-03-01 to
2024-02-29
2022-03-01 to
2023-02-28
2022-03-01 to
2023-02-28
2022-03-01 to
2023-02-28
2022-03-01 to
2023-02-28
2022-03-01 to
2023-02-28
Year to quarter end consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
14,431,000,000 JPY
9,855,000,000 JPY
9,855,000,000 JPY
9,855,000,000 JPY
9,855,000,000 JPY
12,126,000,000 JPY
10,414,000,000 JPY
10,414,000,000 JPY
10,414,000,000 JPY
10,414,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
4,887,000,000 JPY
1,991,000,000 JPY
Foreign currency translation adjustment
5,874,000,000 JPY
10,188,000,000 JPY
Remeasurements of defined benefit plans, net of tax
428,000,000 JPY
-456,000,000 JPY
Share of other comprehensive income of entities accounted for using equity method
104,000,000 JPY
-5,000,000 JPY
Other comprehensive income
11,295,000,000 JPY
11,718,000,000 JPY
Comprehensive income
25,727,000,000 JPY
23,844,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
25,193,000,000 JPY
23,458,000,000 JPY
Comprehensive income attributable to non-controlling interests
533,000,000 JPY
386,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.